Vir Biotechnology (VIR) Free Cash Flow (2018 - 2026)
Vir Biotechnology (VIR) free cash flow from Sep 30, 2018 to Mar 31, 2026. The TTM Vir Biotechnology (VIR) free cash flow is -$450M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Vir Biotechnology (VIR) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +6.52% |
| 5 Years TTM | +13.57% |
| All Time TTM | +26.39% |
Annual Free Cash Flow change of Vir Biotechnology (VIR)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$133M | -66.52% |
| 2025 | -$397M | -12.57% |
| 2024 | -$454M | -43.32% |
| 2023 | -$800M | -150.17% |
| 2022 | $1.60B | -2398.26% |
| 2021 | -$69M | -64.85% |
| 2020 | -$197M | +42.52% |
| 2019 | -$139M | +35.47% |
| 2018 | -$102M | +47.99% |
| 2017 | -$69M | N/A |
Comparison Vir Biotechnology (VIR) five years free cash flow CAGR with competitors
Vir Biotechnology (VIR) five years free cash flow CAGR is 13.57%.